Villejuif, 11 february 2020.
Professor Fabrice André appointed as Research Director at Gustave Roussy
Professor Fabrice André has been appointed as Director of Research at Gustave Roussy by the Minister of Health and Welfare, Madame Agnès Buzyn, and the Minister of Higher Education, Research and Innovation, Madame Frédérique Vidal. He takes up his post on the 11th of February, for a five year term. He follows Professor Eric Solary who has occupied the position since 2011.
In his new role, Professor André will seek to create the best environment to enable Gustave Roussy research workers to contribute to medical advances with a major impact for society.
With this objective, he will work with the Medical Director of the Institute to coordinate the clinical and scientific research programmes identified in the upcoming Hospital Plan. He will also be responsible for the development of research at Gustave Roussy by ensuring the continued success of those units that exist at present and by promoting new research teams and recognition of them, He will thus develop a health-sciences orientated laboratory structure based at the Institute. In addition, he will strengthen inter-disciplinary collaboration within the French research community and extend the scientific fields covered at Gustave Roussy, in particular by opening them up to work in artificial intelligence, physics and the human and social sciences.
Professor André is aged 47. He is a consultant medical oncologist specialising in breast cancer and professor of medicine at the Paris-Saclay University. He is head of the Inserm U981 Research Unit, “Predictive Biomarkers and New Therapeutic Strategies in Oncology”. His work combines various complementary techniques and ranges from basic scientific to clinical research in oncology, while employing bioinformatics and biotechnologies. He is the coordinator of three projects financed by “Investissements d’avenir” (Investments for the Future, a French national programme): the CANTO cohort, the MyProbe Hospital/University health research project, and the PRISM study funded by the national centre for precision medicine.
Professor André is author or co-author of 350 scientific articles published in international journals and he appears in the list of most highly cited researchers in the world (Highly cited researchers list, Web of Science Group) and in the BIS Research think-tank group of the 25 most influential individuals in the precision medicine field. He has received both the Young Investigator and Career Development Award prizes from the American Society of Clinical Oncology (ASCO). He is the editor-in-chief of the prestigious international journal, Annals of Oncology.
